Airway Management Devices Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	126 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224254

Best Price Guarantee
Price	from $4,850
Length	126 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224254

Airway Management Devices Market

Growth Factors of Airway Management Devices Market

The airway management devices market size was valued at USD 1.96 billion in 2023, and the market is now projected to grow from USD 2.05 billion in 2024 to USD 2.94 billion by 2032, exhibiting a CAGR of 4.6% during the forecast period of 2024-2032.

Due to the COVID-19 outbreak and social restrictions in 2020, there were factors such as mobility restrictions and resource constraints affecting airway management devices market growth. However, the delayed elective procedures rose at some point to offset initial shutdowns and the plan increased overall inpatient admissions worldwide. This rise intensified the need for devices in anaesthetic and surgical procedures, thus contributing to the growth of the market in 2021.

The rising incidence of respiratory diseases is a major factor influencing the growth of the airway medical devices market share. The industry’s key stakeholders are increasing production capacity and engaging in research partnerships to create new products. Currently, there is interest in developing new airway management devices for the adult and neonatal patients. Increased spending on research and development, and increased production are anticipated to increase the number of devices in developing countries.

Further, the global figures for preterm births are speeding up the emergence of breathing impairments in neonates, subsequently propelling the need for airway management apparatuses. Such factors include infections and changes in lifestyles with this trend. New products such as advanced airway devices designed for pediatric patients are being launched by key companies thereby driving market growth. This means that more children are being born with respiratory-related complications hence the need for these devices.

Comprehensive Analysis of Airway Management Devices Market

Market segmentation is one of the key factors that contribute to the upward swing of both the airway management devices market and the healthcare industry. This market expansion offers a comprehensive regional review taking into account the prevailing supply and demand dynamics that define the medical device sector. These segmentations are systematically separated by types, by applications and by end users. The types include, Infraglottic Airway Management Devices [Endotracheal Tubes and Tracheostomy Tubes], Supraglottic Airway Management Devices [Oropharyngeal Airways (OPAS), Laryngeal Mask Airways (LMAS), and Nasopharyngeal Airways], Laryngoscopes and Others. The applications include, Anesthesia, Emergency Medicine and Others. The end-users include, Hospitals & ASCs, Homecare and Others.

North America's airway management market was USD 0.93 billion in 2023 and is expected to lead the global market. Increased demand for research and development, and the introduction of new technologies, by the market players are contributing to the growth of the market size. New product approvals and collaborations among different manufacturers are adding to the growth of the regional market throughout the forecast period.

The key participants in the market have a significant impact in the sphere of healthcare providing the industrial prospectus and setting market trends. These players include, Medtronic (Ireland), Teleflex Incorporated (U.S.), KARL STORZ SE & Co. KG (Germany), ICU Medical (U.S.), Convatec Inc. (U.K.), Ambu A/S (Denmark), Intersurgical Ltd (U.K.), VBM Medizintechnik GmbH (Germany), VYAIRE MEDICAL, INC. (U.S.) and Flexicare (Group) Limited (U.K.). These market players provide a level-playing competitive landscape.

In June 2023, Airway Management department introduced new airway devices under the product category, Morf Nasal Mask.

Segmentation Table

Global Airway Management Devices Market Scope

Study Period 2019-2032

Base Year 2023

Forecast Period 2024-2032

Growth Rate CAGR of 4.6% from 2024 to 2032

Historical Period 2019-2022

Unit Value (USD Billion)

Segmentation By Type, Application, End-user, and Region

By Type

Infraglottic Airway Management Devices

Endotracheal Tubes
Tracheostomy Tubes
Supraglottic Airway Management Devices
Oropharyngeal Airways (OPAS)
Laryngeal Mask Airways (LMAS)
Nasopharyngeal Airways
Laryngoscopes
Others

By Application

Anesthesia

Emergency Medicine
Others

By End-User

Hospitals & ASCs

Home care
Others

By Region

North America (By Type, Application, End User and Country)

U.S. (By Application)
Canada (By Application)
Europe (By Type, By Application, End User and Country/Sub-Region)
Germany (By Application)
France (By Application)
U.K. (By Application)
Spain (By Application)
Italy (By Application)
Rest of Europe (By Application)
Asia Pacific (By Type, Application, End User and Country/Sub-Region)
China (By Application)
India (By Application)
Southeast Asia (By Application)
Japan (By Application)
Australia (By Application)
Rest of Asia Pacific (By Application)
Latin America (By Type, Application, End User and Country/Sub-Region)
Mexico (By Application)
Brazil (By Application)
Rest of Latin America (By Application)
Middle East and Africa (By Type, End User, and Country/Sub-Region)
GCC (By Application)
South Africa (By Application)
Rest of MEA (By Application)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Prevalence of Chronic Obstructive Pulmonary Disease, By Key Countries/Sub-Region, 2022/2023; 4.2. Prevalence of Asthma, By Key Countries, 2022/2023; 4.3. New Product Launches, By Key Players; 4.4. Key Industry Developments: Mergers, Partnerships, & Acquisitions, By Key Players; 4.5. Impact of COVID-19 on Global Airway Management Devices Market
5. Global Airway Management Devices Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Type; 5.1.1. Infraglottic Airway Management Devices; 5.1.1.1. Tracheostomy Tubes; 5.1.1.2. Endotracheal Tubes (ETTS); 5.1.2. Supraglottic Airway Management Devices; 5.1.2.1. Oropharyngeal Airways (OPAS); 5.1.2.2. Laryngeal Mask Airways (LMAS); 5.1.2.3. Nasopharyngeal Airways; 5.1.3. Laryngoscopes; 5.1.4. Others; 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Anesthesia; 5.2.2. Emergency Medicine; 5.2.3. Others; 5.3. Market Analysis, Insights and Forecast – By End User; 5.3.1. Hospitals & ASCs; 5.3.2. Home Care; 5.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By Region; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East & Africa
6. North America Airway Management Devices Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Type; 6.1.1. Infraglottic Airway Management Devices; 6.1.1.1. Tracheostomy Tubes; 6.1.1.2. Endotracheal Tubes (ETTS); 6.1.2. Supraglottic Airway Management Devices; 6.1.2.1. Oropharyngeal Airways (OPAS); 6.1.2.2. Laryngeal Mask Airways (LMAS); 6.1.2.3. Nasopharyngeal Airways; 6.1.3. Laryngoscopes; 6.1.4. Others; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Anesthesia; 6.2.2. Emergency Medicine; 6.2.3. Others; 6.3. Market Analysis, Insights and Forecast – By End User; 6.3.1. Hospitals & ASCs; 6.3.2. Home Care; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By Country; 6.4.1. U.S.; 6.4.1.1. By Application; 6.4.2. Canada; 6.4.2.1. By Application
7. Europe Airway Management Devices Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Type; 7.1.1. Infraglottic Airway Management Devices; 7.1.1.1. Tracheostomy Tubes; 7.1.1.2. Endotracheal Tubes (ETTS); 7.1.2. Supraglottic Airway Management Devices; 7.1.2.1. Oropharyngeal Airways (OPAS); 7.1.2.2. Laryngeal Mask Airways (LMAS); 7.1.2.3. Nasopharyngeal Airways; 7.1.3. Laryngoscopes; 7.1.4. Others; 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Anesthesia; 7.2.2. Emergency Medicine; 7.2.3. Others; 7.3. Market Analysis, Insights and Forecast – By End User; 7.3.1. Hospitals & ASCs; 7.3.2. Home Care; 7.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 7.4.1. Germany; 7.4.1.1. By Application; 7.4.2. Spain; 7.4.2.1. By Application; 7.4.3. France; 7.4.3.1. By Application; 7.4.4. Italy; 7.4.4.1. By Application; 7.4.5. U.K.; 7.4.5.1. By Application; 7.4.6. Rest of Europe; 7.4.6.1. By Application
8. Asia Pacific Airway Management Devices Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Type; 8.1.1. Infraglottic Airway Management Devices; 8.1.1.1. Tracheostomy Tubes; 8.1.1.2. Endotracheal Tubes (ETTS); 8.1.2. Supraglottic Airway Management Devices; 8.1.2.1. Oropharyngeal Airways (OPAS); 8.1.2.2. Laryngeal Mask Airways (LMAS); 8.1.2.3. Nasopharyngeal Airways; 8.1.3. Laryngoscopes; 8.1.4. Others; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Anesthesia; 8.2.2. Emergency Medicine; 8.2.3. Others; 8.3. Market Analysis, Insights and Forecast – By End User; 8.3.1. Hospitals & ASCs; 8.3.2. Home Care; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 8.4.1. China; 8.4.1.1. By Application; 8.4.2. India; 8.4.2.1. By Application; 8.4.3. Southeast Asia; 8.4.3.1. By Application; 8.4.4. Japan; 8.4.4.1. By Application; 8.4.5. Australia; 8.4.5.1. By Application; 8.4.6. Rest of Asia Pacific; 8.4.6.1. By Application
9. Latin America Airway Management Devices Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Type; 9.1.1. Infraglottic Airway Management Devices; 9.1.1.1. Tracheostomy Tubes; 9.1.1.2. Endotracheal Tubes (ETTS); 9.1.2. Supraglottic Airway Management Devices; 9.1.2.1. Oropharyngeal Airways (OPAS); 9.1.2.2. Laryngeal Mask Airways (LMAS); 9.1.2.3. Nasopharyngeal Airways; 9.1.3. Laryngoscopes; 9.1.4. Others; 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Anesthesia; 9.2.2. Emergency Medicine; 9.2.3. Others; 9.3. Market Analysis, Insights and Forecast – By End User; 9.3.1. Hospitals & ASCs; 9.3.2. Home Care; 9.3.3. Others; 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 9.4.1. Brazil; 9.4.1.1. By Application; 9.4.2. Mexico; 9.4.2.1. By Application; 9.4.3. Rest of Latin America; 9.4.3.1. By Application
10. Middle East & Africa Airway Management Devices Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Type; 10.1.1. Infraglottic Airway Management Devices; 10.1.1.1. Tracheostomy Tubes; 10.1.1.2. Endotracheal Tubes (ETTS); 10.1.2. Supraglottic Airway Management Devices; 10.1.2.1. Oropharyngeal Airways (OPAS); 10.1.2.2. Laryngeal Mask Airways (LMAS); 10.1.2.3. Nasopharyngeal Airways; 10.1.3. Laryngoscopes; 10.1.4. Others; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Anesthesia; 10.2.2. Emergency Medicine; 10.2.3. Others; 10.3. Market Analysis, Insights and Forecast – By End User; 10.3.1. Hospitals & ASCs; 10.3.2. Home Care; 10.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 10.4.1. GCC; 10.4.1.1. By Application; 10.4.2. South Africa; 10.4.2.1. By Application; 10.4.3. Rest of Middle East & Africa; 10.4.3.1. By Application
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Medtronic; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Teleflex Incorporated; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. KARL STORZ SE & Co. KG; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. ICU Medical; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Convatec Inc.; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Ambu A/S; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Intersurgical Ltd; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. VBM Medizintechnik GmbH; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. VYAIRE MEDICAL, INC.; 11.2.9.1. Overview; 11.2.9.2. Products & Services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability); 11.2.10. Flexicare (Group) Limited; 11.2.10.1. Overview; 11.2.10.2. Products & Services; 11.2.10.3. SWOT Analysis; 11.2.10.4. Recent Developments; 11.2.10.5. Strategies; 11.2.10.6. Financials (Based on Availability)